Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowJanuary 26, 2026 — 3:45 PM - 4:15 PM ET
Nasdaq MarketSite, 4 Times Square, New York
Maze Therapeutics (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Jason Coloma, CEO, rings the Closing Bell.
